Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome
Baldini, C.; Notarstefano, C.; Pepe, P.; Ferro, F.; Luciano, N.; Tani, C.; Talarico, R.; Mosca, M.
Clinical and Experimental Rheumatology 31(1): 160
2013
ISSN/ISBN: 0392-856X PMID: 23021087 Document Number: 668381
Document emailed within 1 workday
Related Documents
Wang, C.; Fortin, P.R.; Li, Y.; Panaritis, T.; Gans, M.; Esdaile, J.M. 1999: Discontinuation of antimalarial drugs in systemic lupus erythematosus Journal of Rheumatology 26(4): 808-815Tabsh, K.; Rizzo, W.B.; Holbrook, K.; Theroux, N. 1993: Sjögren-Larsson syndrome: technique and timing of prenatal diagnosis Obstetrics and Gynecology 82(4 Pt 2(Suppl): 700-703
Brito-Zerón, P.; Acar-Denizli, N.; Ng, W.-F.; Zeher, M.; Rasmussen, A.; Mandl, T.; Seror, R.; Li, X.; Baldini, C.; Gottenberg, J.-E.; Danda, D.; Quartuccio, L.; Priori, R.; Hernandez-Molina, G.; Armagan, B.; Kruize, A.A.; Kwok, S.-K.; Kvarnström, M.; Praprotnik, S.; Sène, D.; Bartoloni, E.; Solans, R.; Rischmueller, M.; Suzuki, Y.; Isenberg, D.A.; Valim, V.; Wiland, P.; Nordmark, G.; Fraile, G.; Bootsma, H.; Nakamura, T.; Giacomelli, R.; Devauchelle-Pensec, V.; Knopf, A.; Bombardieri, M.; Trevisani, V.-F.; Hammenfors, D.; Pasoto, S.G.; Retamozo, S.; Gheita, T.A.; Atzeni, F.; Morel, J.; Vollenveider, C.; Horvath, I.-F.; Sivils, K.L.; Olsson, P.; De Vita, S.; Sánchez-Guerrero, J.; Kilic, L.; Wahren-Herlenius, M.; Mariette, X.; Ramos-Casal 2018: How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project) Clinical and Experimental Rheumatology 36 Suppl 112(3): 102-112
Kong, F.; Li, J-Xin.; Li, P.; Li, Y-Zhe.; Zhang, F-Chun.; Zhang, J. 2013: Association of TNFSF4 polymorphisms with susceptibility to primary Sjögren's syndrome and primary biliary cirrhosis in a Chinese Han population Clinical and Experimental Rheumatology 31(4): 546-551
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Lin, Y.-K.; Yang, F.-C.; Liu, F.-C.; Lee, J.-T.; Sung, Y.-F. 2016: Co-Cccurrence of Guillain-Barre Syndrome and Primary Sjögren Syndrome in an Elderly Woman Acta Neurologica Taiwanica 25(3): 83-87
Thorel, J.B.; Deshayes, P. 1981: Digital necrosis disclosing Reynolds' syndrome (primary biliary cirrhosis and scleroderma) with Gougerot-Sjögren syndrome La Nouvelle Presse Medicale 10(27): 2295-2296
Nelson, J.D.; Friedlaender, M.; Yeatts, R.P.; Yee, R.; McDermott, M.; Orlin, S.; Gallagher, S.C.; Shrotriya, R.C. 1998: Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. the MGi PHARMA Sjögren's Syndrome Study Group Advances in Experimental Medicine and Biology 438: 979-983
Gran, J.T.; Myklebust, G. 2001: Diagnosis of primary Sjogren's syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(5): 563-566
Nishiyama, S.; Miyawaki, S.; Hashimoto, T. 1995: Cutaneous manifestations of primary Sjögren's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 53(10): 2551-2556
Shimode, K.; Kobayashi, S.; Kitani, M.; Okada, K.; Tsunematsu, T. 1986: Optic neuritis in primary Sjögren's syndrome Rinsho Shinkeigaku 26(5): 433-436
Pflugfelder, S.C.; Roussel, T.J.; Culbertson, W.W. 1987: Primary Sjögren's syndrome after infectious mononucleosis JAMA 257(8): 1049-1050
Wang, L.; Zhao, Y.; Zhang, F.-c. 2010: Malignant lymphoma associated with primary Sjögren's syndrome Zhonghua Yi Xue Za Zhi 90(39): 2773-2775
Sabio, J.M.; Milla, E.; Jiménez-Alonso, J. 2001: A multicase family with primary Sjögren's syndrome Journal of Rheumatology 28(8): 1932-1934
Drosos, A.A.; Andonopoulos, A.P.; Lagos, G.; Angelopoulos, N.V.; Moutsopoulos, H.M. 1989: Neuropsychiatric abnormalities in primary Sjögren's syndrome Clinical and Experimental Rheumatology 7(2): 207-209
Valtýsdóttir, S.T.; Gudbjörnsson, B.; Hällgren, R.; Hetta, J. 2000: Psychological well-being in patients with primary Sjögren's syndrome Clinical and Experimental Rheumatology 18(5): 597-600
Campello-Morer, I.; López-Gastón, J.I.; Gracia-Naya, M. 2001: Subacute polyradiculoneuropathy associated with primary Sjogren syndrome Revista de Neurologia 32(11): 1100
Schoonbrood, T.H.; Hannema, A.; Fijen, C.A.; Markusse, H.M.; Swaak, A.J. 1995: C5 deficiency in a patient with primary Sjögren's syndrome Journal of Rheumatology 22(7): 1389-1390
Ostuni, P.A.; Germana, B.; Di Mario, F.; Rugge, M.; Plebani, M.; De Zambiasi, P.; Naccarato, R.; Gambari, P.F. 1993: Gastric involvement in primary Sjögren's syndrome Clinical and Experimental Rheumatology 11(1): 21-25
Tzioufas, A.G.; Goules, A.V. 2019: The necessity of novel biomarkers in primary Sjögren's syndrome Clinical and Experimental Rheumatology 37 Suppl 118(3): 16-18